These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38035530)

  • 1. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a heterozygous TPM1-E192K knock-in human induced pluripotent stem cell line using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Aug; 63():102878. PubMed ID: 35917600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Oct; 64():102901. PubMed ID: 36037555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line.
    Pachernegg S; Robevska G; Ferreira LGA; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103494. PubMed ID: 39003885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
    Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
    Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of heterozygous (MCRIi031-A-1) and homozygous (MCRIi031-A-2) SOX9 knockout human iPSC lines.
    Pachernegg S; Robevska G; G A Ferreira L; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103484. PubMed ID: 38924973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of heterozygous (MCRIi030-A-1) and homozygous (MCRIi030-A-2) NR2F2/COUP-TFII knockout human iPSC lines.
    Ferreira LGA; Cabral-da-Silva MC; Pachernegg S; van den Bergen JA; Robevska G; Vlahos K; Howden SE; Ng ES; Dias-da-Silva MR; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Apr; 76():103374. PubMed ID: 38458031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of miR-15a/16-1 cluster-deficient human induced pluripotent stem cell line (DMBi001-A-2) using CRISPR/Cas9 gene editing.
    Stępniewski J; Jeż M; Dulak J
    Stem Cell Res; 2023 Apr; 68():103046. PubMed ID: 36801567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a heterozygous SCN5A knockout human induced pluripotent stem cell line by CRISPR/Cas9 edition.
    Gizon M; Duboscq-Bidot L; El Kassar L; Bobin P; Ader F; Giraud-Triboult K; Charron P; Villard E; Fontaine V; Neyroud N
    Stem Cell Res; 2022 Apr; 60():102680. PubMed ID: 35093717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
    Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
    Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9.
    Ratnavadivel S; Dammeier J; Gaertner A; de Toledo MAS; Zenke M; Gummert J; Bloch Rasmussen T; Klinke N; Jürgens K; Meyer H; Paululat A; Milting H
    Stem Cell Res; 2024 Apr; 76():103354. PubMed ID: 38430734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing.
    Bu Q; Zhang H; Liu Q; Dai Y; Wei Q; Xue A; Huang Y; Zhong K; Huang Y; Gao H; Cen X
    Stem Cell Res; 2020 Dec; 49():102052. PubMed ID: 33130469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
    Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
    Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
    Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
    Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.